Trial Details
UNKNOWNBasic Information
| Clinical ID | c76 |
|---|---|
| Identifier | NCT04404517 |
| Trial Title | Correlation of Serum Adalimumab Levels at an Administration of 40 mg Weekly vs 80 mg Every Two Weeks |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases |
| Interventions | DRUG: Adalimumab |
Participant Information
| Sponsor | Hospital Universitario La Paz |
|---|---|
| City | Madrid |
| Country/Region | Spain |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2019-10-01 |
|---|---|
| Primary Completion Date | 2021-09-30 |
| Completion Date | 2021-10-30 |